Critical Comparison: Prenetics Global (NASDAQ:PRE) vs. Olink Holding AB (publ) (NASDAQ:OLK)

Prenetics Global (NASDAQ:PRE) and Olink Holding AB (publ) (NASDAQ:OLK) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Analyst Ratings

This is a breakdown of current ratings for Prenetics Global and Olink Holding AB (publ), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	0	0	1	0	3.00
Olink Holding AB (publ)	0	4	0	0	2.00

Prenetics Global currently has a consensus price target of $9.00, suggesting a potential upside of 69.17%. Olink Holding AB (publ) has a consensus price target of $26.00, suggesting a potential downside of 0.31%. Given Prenetics Global’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Prenetics Global is more favorable than Olink Holding AB (publ).

Profitability

This table compares Prenetics Global and Olink Holding AB (publ)’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-282.96%	-10.76%	-8.79%
Olink Holding AB (publ)	-19.72%	-7.07%	-6.05%

Volatility and Risk

Prenetics Global has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500. Comparatively, Olink Holding AB (publ) has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.

Insider & Institutional Ownership

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 30.2% of Olink Holding AB (publ) shares are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 5.2% of Olink Holding AB (publ) shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Prenetics Global and Olink Holding AB (publ)’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$21.74 million	2.24	-$62.72 million	($4.45)	-1.20
Olink Holding AB (publ)	$170.89 million	18.98	-$31.60 million	($0.27)	-96.59

Olink Holding AB (publ) has higher revenue and earnings than Prenetics Global. Olink Holding AB (publ) is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Summary

Olink Holding AB (publ) beats Prenetics Global on 9 of the 14 factors compared between the two stocks.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.